THIS is the young mother and businesswoman who beat breast cancer and went on to be appointed as the first female boss of food group Glanbia.
Siobhan Talbot discovered she had breast cancer in September 2010.
But less than three years later, she has completely recovered and is taking on a new challenge as head of the food giant.
This is only the second time there has been a female chief executive of an Irish publicly- listed company – recruitment firm CPL Resources is the other.
Glanbia announced yesterday that its current boss, John Moloney, is to retire at the end of June after 12 years at the helm.
Ms Talbot is the current group finance director and will take up her new position from the beginning of next month.
Ms Talbot has been with the company for over a decade and took up the role as group finance director in 2009.
She originally joined in 1992 and became a member of the group operating executive in 2000.
By 2005, Ms Talbot took up the role of deputy finance director and her role included taking responsibility for strategic planning.
She is a fellow of the Institute of Chartered Accountants in Ireland.
John Moloney said that he was satisfied that Ms Talbot will steer the group in the right direction.
"I feel that after 12 years at the helm and over 25 years with the group it is the right time for all concerned to pass the leadership of Glanbia to someone new," said Moloney.
"I am delighted that Siobhan Talbot has been appointed as my successor.
"She brings a drive, energy, deep knowledge and commitment to her role that will move the group to the next phase of growth and development."
Brian Phelan will take up the role of chief executive of global ingredients, a newly-formed business segment incorporating the US cheese business, as well as global nutritionals' ingredients technologies and customised pre-mix solutions.
And Hugh McGuire has been appointed to the board as an executive director with responsibility for global performance nutrition.
At the company's AGM in Kilkenny this week, chairman Liam Herlihy told shareholders the prospects for 2013 are good.
"Trading is in line with expectations and this trend is set to continue with growth driven by the US cheese and global nutritionals segment and, in particular, performance nutrition," he said.
"The 2013 outlook is reiterated with forecast adjusted earnings per share growth, on a constant currency basis, of between 8pc and 10pc for the full year."
The company reported a 9pc rise in revenue for the last year.